​

Kronos Bio Ownership | Who Owns Kronos Bio?

OverviewForecastRevenueFinancialsChart

Kronos Bio Ownership Summary

Kronos Bio is owned by 23.23% institutional investors, 26.88% insiders, and 49.89% retail investors. Vida ventures advisors is the largest institutional shareholder, holding 4.58% of KRON shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.18% of its assets in Kronos Bio shares.

KRON Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKronos Bio23.23%26.88%49.89%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vida ventures advisors2.77M4.58%$2.63M
Vanguard group1.92M3.19%$1.83M
Millennium management1.72M2.85%$1.63M
Alphabet1.44M2.38%$1.37M
Acadian asset management1.30M2.16%$1.24M
Wildcat capital management1.30M2.15%$1.23M
Renaissance1.17M1.94%$1.11M
Tang capital management1.00M1.66%$953.21K
Blackrock874.10K1.47%$1.08M
Artal group842.95K1.42%$1.05M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vida ventures advisors2.77M1.80%$2.63M
Wildcat capital management1.30M0.49%$1.23M
Alphabet1.44M0.08%$1.37M
Tang capital management1.00M0.06%$953.21K
Forefront analytics93.19K0.04%$88.53K
Deltec asset management200.00K0.04%$190.00K
Siren842.95K0.04%$800.81K
Velan capital investment management lp35.00K0.03%$33.25K
Artal group842.95K0.03%$1.05M
Ground swell capital11.92K0.02%$11.32K

Top Buyers

HolderShares% AssetsChange
Tang capital management1.00M0.06%1.00M
Jacobs levy equity management440.74K0.00%381.34K
Deltec asset management200.00K0.04%200.00K
Renaissance1.17M0.00%192.75K
Gilead sciences188.57K0.01%188.57K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---2.91M
Partners capital investment group, llp527.50K0.01%-1.08M
Mariner---1.04M
Omega fund management---955.87K
Acuitas investments---554.50K

New Positions

HolderShares% AssetsChangeValue
Tang capital management1.00M0.06%1.00M$953.21K
Deltec asset management200.00K0.04%200.00K$190.00K
Gilead sciences188.57K0.01%188.57K$179.14K
Squarepoint ops98.42K0.00%98.42K$93.50K
Velan capital investment management lp35.00K0.03%35.00K$33.25K

Sold Out

HolderChange
Qube research-297.00
Wells fargo & company/mn-347.00
Citigroup-724.00
Point72 asia (singapore) pte.-12.25K
Virtu financial-14.11K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202428-48.15%14,008,974-28.90%232.18%9-50.00%6-60.00%
Sep 30, 202453-5.36%19,689,996-4.63%322.71%17-19.05%157.14%
Jun 30, 202456-3.45%20,645,660-4.86%342.46%215.00%14-12.50%
Mar 31, 202458-1.69%21,700,397-18.86%371.78%2011.11%16-5.88%
Dec 31, 202359-7.81%26,745,874-11.63%451.65%185.88%17-19.05%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.32M2.18%-
Vanguard US Total Market Shares ETF1.32M2.16%-
Vanguard Institutional Extnd Mkt Idx Tr559.54K0.93%-
Fidelity Extended Market Index235.55K0.39%-1.50K
Kennedy Micro Cap Opportunities148.07K0.25%11.66K
Bridgeway Ultra-Small Company Market118.93K0.20%-
iShares Micro-Cap ETF101.37K0.17%-
Forefront Tiresias Strategy86.58K0.14%2.19K
Bridgeway Ultra-Small Company77.47K0.13%-115.30K
Fidelity Total Market Index76.18K0.12%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 27, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$478.84K
Jun 28, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$254.96K
Jun 11, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$814.57K
Jun 10, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$1.21M
Jun 12, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$1.10M

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q25-
2024 Q1-6
2023 Q432
2023 Q3-3

KRON Ownership FAQ

Who Owns Kronos Bio?

Kronos Bio shareholders are primarily institutional investors at 23.23%, followed by 26.88% insiders and 49.89% retail investors. The average institutional ownership in Kronos Bio's industry, Biotech Stocks , is 68.48%, which Kronos Bio falls below.

Who owns the most shares of Kronos Bio?

Kronos Bio’s largest shareholders are Vida ventures advisors (2.77M shares, 4.58%), Vanguard group (1.92M shares, 3.19%), and Millennium management (1.72M shares, 2.85%). Together, they hold 10.62% of Kronos Bio’s total shares outstanding.

Does Blackrock own Kronos Bio?

Yes, BlackRock owns 1.47% of Kronos Bio, totaling 874.1K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.08M$. In the last quarter, BlackRock decreased its holdings by -35.348K shares, a -3.89% change.

Who is Kronos Bio’s biggest shareholder by percentage of total assets invested?

Vida ventures advisors is Kronos Bio’s biggest shareholder by percentage of total assets invested, with 1.80% of its assets in 2.77M Kronos Bio shares, valued at 2.63M$.

Who is the top mutual fund holder of Kronos Bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Kronos Bio shares, with 2.18% of its total shares outstanding invested in 1.32M Kronos Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools